Exhale

The official blog of the Lung Institute.

Stop Managing, Start Treating

5 Jan 2015
| Under Lung Disease | Posted by
| 2 Comments
Stop Managing, Start Treating

New Year… New Ways to Treat Your Lung Disease

You have a lung disease and have been managing the symptoms for as long as you can remember. You know how much the coughing hurts, the feelings of constantly being exhausted and the constant struggle to just breathe normally. Your chronic lung disease IS taking a toll on how you live each vibrant day. Isn’t it about time that you stop managing your disease and start treating it?

You Have Options

Chronic conditions such as COPD, interstitial lung disease and pulmonary fibrosis cannot be cured, but the progression and symptoms of these conditions can be treated through the use of cellular therapy. We know every patient is unique and no two conditions are identical. With this in mind, the treatments available at the Lung Institute are based on an individual’s specific needs, which ensures the best possible outcome. We have seen and shared stories from several of our patients that have benefited from cellular therapy.

Today, the Lung Institute is using adult cells harvested from the patient’s own blood or bone marrow to provide healing results for people with lung diseases. So far, we have treated well over 500 patients. They separate the cells and reintroduce them into the patient’s body. The result is that the healthy cells replace the damaged ones found in the lungs.

If the number of people who have already been successfully treated with cells is any indication of the future, then it will undoubtedly be heralded as one of the ground-breaking medical technologies of its time. If you or a loved one suffers from a chronic lung disease and wants to learn more about treatment optionscontact us or call us at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.